4.8 Article

Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers

期刊

ONCOGENE
卷 30, 期 34, 页码 3672-3681

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2011.73

关键词

Hsp27; HspB1; peptide aptamers; proliferation; apoptosis; therapeutic target

资金

  1. Comite du Rhone of la Ligue Contre le Cancer
  2. Region Rhone-Alpes and Retina France
  3. La Region Rhone-Alpes

向作者/读者索取更多资源

Human heat shock protein 27 (Hsp27, HspB1) is an antiapoptotic protein characterized for its tumorigenic and metastatic properties, and now referenced as a major therapeutic target in many types of cancer. Hsp27 biochemical properties rely on a structural oligomeric and dynamic organization. Downregulation by small interfering RNA or inhibition with dominant-negative mutant have proven their efficiency to counteract the antiapoptotic and protective properties of Hsp27. In this study, we report the isolation and characterization of Hsp27-targeted molecules interfering with its structural organization. Using the peptide aptamer (PA) strategy, we isolated PAs that specifically interact with Hsp27 and not with the other members of the small heat shock protein family. In mammalian cell cultures, PAs expression perturbed the dimerization and oligomerization of Hsp27, and acted as negative regulators of the antiapoptotic and cytoprotective activities of this protein. Further studies analyzing SQ20B cell xenografts in immunocompromised mice showed that PAs strongly reduced tumor development through cell cycle arrest. Our data suggest that PAs could provide a potential tool to develop strategies for the discovery of Hsp27 chemical inhibitors. Oncogene (2011) 30, 3672-3681; doi:10.1038/onc.2011.73;published online 21 March 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First Small-Molecule Inhibitors

Thomas Robert, Jared L. Johnson, Roxane Guichaoua, Tomer M. Yaron, Stephane Bach, Lewis C. Cantley, Pierre Colas

FRONTIERS IN CHEMISTRY (2020)

Review Medicine, Research & Experimental

Budding yeast, a model and a tool ... also for biomedical research

Stephane Bach, Pierre Colas, Marc Blondel

M S-MEDECINE SCIENCES (2020)

Article Chemistry, Medicinal

Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potency

Nada Ibrahim, Pascal Bonnet, Jean-Daniel Brion, Jean-Francois Peyrat, Jerome Bignon, Helene Levaique, Beatrice Josselin, Thomas Robert, Pierre Colas, Stephane Bach, Samir Messaoudi, Mouad Alami, Abdallah Hamze

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Genetics & Heredity

Cyclin-dependent kinases and rare developmental disorders

Pierre Colas

ORPHANET JOURNAL OF RARE DISEASES (2020)

Article Cell Biology

Failed Apoptosis Enhances Melanoma Cancer Cell Aggressiveness

Kevin Berthenet, Camila Castillo Ferrer, Deborah Fanfone, Nikolay Popgeorgiev, David Neves, Philippe Bertolino, Benjamin Gibert, Hector Hernandez-Vargas, Gabriel Ichim

CELL REPORTS (2020)

Article Endocrinology & Metabolism

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study

Laura Gerard, Jessica Garcia, Arnaud Gauthier, Jonathan Lopez, Alice Durand, Valerie Hervieu, Annie Lemelin, Laurence Chardon, Verena Landel, Benjamin Gibert, Catherine Lombard-Bohas, Lea Payen, Thomas Walter

Summary: This study aimed to describe ctDNA mutations in GEPNEC patients and assess their predictive value for response to chemotherapy and disease progression. The results showed a high sensitivity of ctDNA assessment, which is expected to play an important role in the future management of GEPNEC.

NEUROENDOCRINOLOGY (2021)

Article Multidisciplinary Sciences

Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1

Simon Renders, Arthur Flohr Svendsen, Jasper Panten, Nicolas Rama, Maria Maryanovich, Pia Sommerkamp, Luisa Ladel, Anna Rita Redavid, Benjamin Gibert, Seka Lazare, Benjamin Ducarouge, Katharina Schoenberger, Andreas Narr, Manon Tourbez, Bertien Dethmers-Ausema, Erik Zwart, Agnes Hotz-Wagenblatt, Dachuan Zhang, Claudia Korn, Petra Zeisberger, Adriana Przybylla, Markus Sohn, Simon Mendez-Ferrer, Mathias Heikenwaelder, Maik Brune, Daniel Klimmeck, Leonid Bystrykh, Paul S. Frenette, Patrick Mehlen, Gerald de Haan, Nina Cabezas-Wallscheid, Andreas Trumpp

Summary: Haematopoietic stem cells are characterized by their self-renewal potential and dormancy. This study shows that niche-produced netrin-1 preserves HSC quiescence and self-renewal through neogenin-1, with a decline in netrin-1 production during aging leading to decreased Neo1-mediated HSC self-renewal.

NATURE COMMUNICATIONS (2021)

Article Medicine, Research & Experimental

Targeting netrin-3 in small cell lung cancer and neuroblastoma

Shan Jiang, Mathieu Richaud, Pauline Vieugue, Nicolas Rama, Jean-Guy Delcros, Maha Siouda, Mitsuaki Sanada, Anna-Rita Redavid, Benjamin Ducarouge, Maeva Hervieu, Silvia Breusa, Ambroise Manceau, Charles-Henry Gattolliat, Nicolas Gadot, Valerie Combaret, David Neves, Sandra Ortiz-Cuaran, Pierre Saintigny, Olivier Meurette, Thomas Walter, Isabelle Janoueix-Lerosey, Paul Hofman, Peter Mulligan, David Goldshneider, Patrick Mehlen, Benjamin Gibert

Summary: Netrin-3 is specifically expressed in neuroblastoma (NB) and small cell lung cancer (SCLC), showing a mutually exclusive expression pattern with netrin-1 in these tumors. Targeting netrin-3 in NB and SCLC may delay tumor growth and improve overall survival based on preclinical studies.

EMBO MOLECULAR MEDICINE (2021)

Article Genetics & Heredity

Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders

Thomas Robert, Anne-Catherine Dock-Bregeon, Pierre Colas

Summary: The study revealed that the truncated variants of CDK10 and CycM can still form a CDK10/CycM heterodimer, with the CycM variant partially activating CDK10 activity in vitro, while the CDK10 variant remains surprisingly inactive. Furthermore, the CDK10 and CycM variants are shown to be strongly and partially degraded by the proteasome when expressed in human cells.

MOLECULAR GENETICS & GENOMIC MEDICINE (2021)

Article Gastroenterology & Hepatology

Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation

Romain Barnault, Claire Verzeroli, Carole Fournier, Maud Michelet, Anna Rita Redavid, Ievgeniia Chicherova, Marie-Laure Plissonnier, Annie Adrait, Olga Khomich, Fleur Chapus, Mathieu Richaud, Maeva Hervieu, Veronika Reiterer, Federica Grazia Centonze, Julie Lucifora, Birke Bartosch, Michel Rivoire, Hesso Farhan, Yohann Coute, Valbona Mirakaj, Thomas Decaens, Patrick Mehlen, Benjamin Gibert, Fabien Zoulim, Romain Parent

Summary: This study identifies Netrin-1 as an inflammation-inducible factor in the liver and reveals its contribution to hepatic inflammation through an atypical mechanism. Additionally, the study finds that an anti-Netrin-1 antibody has anti-inflammatory activity in hepatic inflammation.

HEPATOLOGY (2022)

Review Biochemistry & Molecular Biology

Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network

Gabriel Ichim, Benjamin Gibert, Sahil Adriouch, Catherine Brenner, Nathalie Davoust, Solange Desagher, David Devos, Svetlana Dokudovskaya, Laurence Dubrez, Jerome Estaquier, Germain Gillet, Isabelle Guenal, Philippe P. Juin, Guido Kroemer, Patrick Legembre, Romain Levayer, Stephen Manon, Patrick Mehlen, Olivier Meurette, Olivier Micheau, Bernar Mignotte, Florence Nguyen-Khac, Nikolay Popgeorgiev, Jean-Lu Poyet, Muriel Priault, Jean-Ehrlan Ricci, Franck B. Riquet, Santos A. Susin, Magal Suzanne, Pierre Vacher, Ludivine Walter, Bertran Mollereau

Summary: Since the Nobel Prize was awarded more than twenty years ago for discovering the core apoptotic pathway in C. elegans, researchers around the world have conducted extensive research on apoptosis and various other forms of regulated cell death. Although there are still many aspects of regulated cell death that need to be clarified in specific cell subtypes and disease conditions, the last decade has seen the description of multiple cell death modalities, some of which have been successfully used in clinical therapy. To keep research into cell death alive, francophone researchers from several institutions in France and Belgium established the French Cell Death Research Network (FCDRN), which is at the forefront of emerging topics in cell death research. These research efforts will enhance our mechanistic knowledge of regulated cell death and its therapeutic applications in the coming years.

BIOMOLECULES (2022)

Article Cell Biology

Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity

A. Huyghe, G. Furlan, J. Schroeder, E. Cascales, A. Trajkova, M. Ruel, F. Studer, M. Larcombe, Y. Bo Yang Sun, F. Mugnier, L. De Matteo, A. Baygin, J. Wang, Y. Yu, N. Rama, B. Gibert, J. Kielbassa, L. Tonon, P. Wajda, N. Gadot, M. Brevet, M. Siouda, P. Mulligan, R. Dante, P. Liu, H. Gronemeyer, M. Mendoza-Parra, J. M. Polo, F. Lavial

Summary: Coordinated changes of cellular plasticity and identity are critical for pluripotent reprogramming and oncogenic transformation. This study provides insights into the partitioned control of cellular plasticity and identity for both regenerative and cancer biology.

NATURE CELL BIOLOGY (2022)

Article Medicine, Research & Experimental

From netrin-1-targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors

David Kryza, Jennifer Wischhusen, Mathieu Richaud, Maeva Hervieu, Jacqueline Sidi Boumedine, Jean-Guy Delcros, Sophie Besse, Thomas Baudier, Pierre-Alexandre Laval, Silvia Breusa, Erwan Boutault, Hugo Clermidy, Nicolas Rama, Benjamin Ducarouge, Mojgan Devouassoux-Shisheboran, Jean-Michel Chezal, Anne-Laure Giraudet, Thomas Walter, Patrick Mehlen, David Sarrut, Benjamin Gibert

Summary: Targeted radionuclide therapy is a revolutionary tool for treating metastatic cancers. This study identifies netrin-1, a molecule known to promote cancer progression, as a potential target for radiotherapy. The development of a therapeutic anti-netrin-1 antibody and an imaging contrast agent allows for the specific detection and treatment of netrin-1-positive tumors. Preclinical studies demonstrate the effectiveness of the therapy in tumor mouse models. These findings suggest that netrin-1 may be a promising target for advanced solid cancers.

EMBO MOLECULAR MEDICINE (2023)

Article Biochemistry & Molecular Biology

Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor

Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurelien Fonseca, Maeva Hervieu, Romeo Berge, Justine Lengrand, Pauline Vieugue, David Neves, Isabelle Goddard, Mathieu Richaud, Pierre-Alexandre Laval, Nicolas Rama, David Goldschneider, Andrea Paradisi, Nicolas Gourdin, Sylvie Chabaud, Isabelle Treilleux, Nicolas Gadot, Isabelle Ray-Coquard, Stephane Depil, Didier Decaudin, Fariba Nemati, Elisabetta Marangoni, Eliane Mery-Lamarche, Catherine Genestie, Severine Tabone-Eglinger, Mojgan Devouassoux-Shisheboran, Kathryn J. Moore, Benjamin Gibert, Patrick Mehlen, Agnes Bernet

Summary: Netrin-1 is an independent prognostic marker for clinical progression of breast and ovary cancers. Interfering with netrin-1 alleviates resistance to chemotherapy and delays tumor relapse, possibly by affecting cancer stem cells. Netrin-1 interference also limits tumor resistance to immune checkpoint inhibitors by reducing the recruitment of a specific type of myeloid-derived suppressor cells. This enhanced anti-tumor efficacy may provide therapeutic opportunities for combining conventional chemotherapies and immunotherapies with netrin-1 interfering drugs.

CELL DEATH AND DIFFERENTIATION (2023)

Article Oncology

The stress sensor GCN2 differentially controls ribosome biogenesis in colon cancer according to the nutritional context

Marie Piecyk, Mouna Triki, Pierre-Alexandre Laval, Cedric Duret, Joelle Fauvre, Laura Cussonneau, Christelle Machon, Jerome Guitton, Nicolas Rama, Benjamin Gibert, Gabriel Ichim, Frederic Catez, Fleur Bourdelais, Sebastien Durand, Jean-Jacques Diaz, Isabelle Coste, Toufic Renno, Serge N. Manie, Nicolas Aznar, Stephane Ansieau, Carole Ferraro-Peyret, Cedric Chaveroux

Summary: Nutrient availability is crucial for tumor cell behavior, with scarcity and glutamine starvation promoting dedifferentiation and chemoresistance. This study reveals that the amino acid sensor GCN2 regulates ribosome biogenesis plasticity and cell fate in colon adenocarcinoma models. Inhibition of the GCN2-MetRS axis improves the efficacy of chemotherapy and induces cell death.

MOLECULAR ONCOLOGY (2023)

暂无数据